TGA publishes AusPAR for Lenvima (lenvatinib mesylate)

9 September 2016 - The TGA has published an AusPAR for Eisai's vascular endothelial growth factor inhibitor inhibitor. ...

Read more →

TGA publishes AusPAR for Opdivo (nivolumab)

7 September 2016 - The TGA has published an AusPAR for BMS' Opdivo. ...

Read more →

TGA approves new indication for Gazyva

5 September 2016 - The TGA has approved a new use for Roche's CD20 receptor antagonist. ...

Read more →

Prime Minister Malcolm Turnbull's lifeline for sufferers of rare diseases: early access to life-saving drugs

4 September 2016 - The Age reports that Health Minister Sussan Ley will release the government's long-awaited response to an independent ...

Read more →

TGA publishes AusPAR for nalfemene hydrochloride dihydrate (Selincro)

2 September 2016 - The TGA has published an AusPAR for Lundbeck's Selincro. ...

Read more →

TGA approves Zepatier

31 August 2016 - The TGA has approved MSD's Zepatier (grazoprevir with elbasvir). ...

Read more →

TGA publishes AusPAR for pirfenidone (Esbriet)

29 August 2016 - The TGA hs published an AusPAR for Roche's Esbriet. ...

Read more →

TGA approves Briviact (brivaracetam)

12 August 2016 - The TGA has approved UCB's Briviact (brivaracetam). ...

Read more →

TGA approves Tagrisso (osimertinib mesylate)

12 August 2016 - The TGA has approved AstraZeneca's Tagrisso (osimertinib mesylate). ...

Read more →

Australia's medicine labels are becoming clearer

9 August 2016 - Medicine labels provide important information about a medicine. Labels must clearly identify a particular medicine and provide ...

Read more →

More on the transparency of public assessment reports in Europe and Australia

6 August 2016 - The TGA and EMA have recently described their experiences in publishing public assessment reports, and reflect ...

Read more →

TGA publishes paper on transparency in medicines regulation

5 August 2016 - Co-authoring with the EMA, the TGA has published a peer-reviewed, free-to-view paper on transparency in medicines regulation. ...

Read more →

TGA publishes AusPAR for Xiaflex

5 August 2016 - The TGA has published an AusPAR for Actelion's Xiaflex (collagenase clostridium histolyticum). ...

Read more →

New biomedical fund to capitalise on our research and entrepreneurial strengths

3 August 2016 - A new fund to accelerate the development and commercialisation of Australian biomedical discoveries is now officially launched. ...

Read more →

TGA approves Belkyra (deoxycholic acid)

28 July 2016 - The TGA has approved Allergan's Belkyra (deoxycholic acid). ...

Read more →